SYPL1: A Protein Involved in Neural Circuit Development and Function

Target Name: SYPL1

NCBI ID: G6856

SYPL1

SYPL1: A Protein Involved in Neural Circuit Development and Function

Synaptophysin-like protein (SYPL1) is a protein that is expressed in various tissues throughout the body, including the brain. It is a member of the synaptophysin family, which is a family of transmembrane proteins that play a critical role in the structure and function of neural circuits. SYPL1 is unique among its family members because it is able to interact with the protein known as neurotrophin, which is a hormone that helps to regulate the growth and development of neurons.

SYPL1 has been shown to play a critical role in the development and maintenance of neural circuits, particularly in the cerebral cortical cortex, which is the outer layer of the brain. It is involved in the formation of synapses, which are the connections between neurons, and it helps to regulate the strength and duration of these connections.

SYPL1 is also involved in the regulation of the ion channels that are responsible for the flow of electrical signals through the neuron. It has been shown to play a critical role in the regulation of the rapid and slow inward current that are generated by these channels.

SYPL1 is a protein that is expressed in the brain, and it is involved in the development and maintenance of neural circuits. It is also involved in the regulation of the flow of electrical signals through the neurons, which is critical for the function of the brain. As a result, SYPL1 may be a drug target or biomarker for a variety of neurological and psychiatric disorders.

Protein Name: Synaptophysin Like 1

The "SYPL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SYPL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets